Skip to content

Ocular Surface Reconstruction With Cultivated Autologus Mucosal Epithelial Transplantation

Ocular Surface Reconstruction With Cultivated Autologus Mucosal Epithelial Transplantation.

Status
UNKNOWN
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01942421
Enrollment
20
Registered
2013-09-16
Start date
2008-01-31
Completion date
2013-12-31
Last updated
2013-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ocular Surface Disease

Keywords

Limbal deficiency, Cultivated limbal transplantation, Ex vivo limbal transplantation, Cultivated autologous mucosal epithelial transplantation

Brief summary

The purpose of this study is to elucidate the appropriate condition of developing cultivated autologous oral mucosal epithelial graft and evaluate the surgical outcome of transplantation of the cultivated cells in the patients.

Detailed description

Ocular surface damage caused by severe ocular surface diseases. Corneal limbal stem cell transplantation has been demonstrated to improve the outcome of ocular surface reconstruction. However, the conventional management of allograft limbal transplantation generally has unsatisfactory outcome because of high risk of rejection and requires long-life immunosuppressive medications. Ocular surface reconstruction with cultivated autologous mucosal epithelial transplantation is served to improve the surgical results of ocular surface reconstruction and decrease the use of immunosuppressive medications

Interventions

PROCEDURECultivated mucosal epithelial transplantation

cultivated autologous mucosal epithelium, then transplant to limbal stem cell deficiency patients.

Sponsors

Mahidol University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Bilateral limbal stem cell deficiency proved by specific clinical features and impression cytology

Exclusion criteria

* Age under 18 * Active ocular infection, Severe dry eye, Uncontrolled glaucoma * Immunocompromised host * Pregnancy

Design outcomes

Primary

MeasureTime frame
Ocular surface clinical and pathological status(signs of limbal deficiency and immunopathological markers)after the surgeryThree years

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026